5 Best Healthcare Technology Stocks To Watch Right Now

��hether it is stocks or socks, I like to buy quality merchandise when it is marked down��- Warren Buffett

A couple of weeks ago, it was announced that consumer gadget giant Apple (AAPL) bought back $14 billion worth of its own stock over the preceding two weeks. In an interview cited by The Wall Street Journal, Apple CEO Tim Cook said the company was ��urprised��by the 8% decline in its shares on Jan. 28, the day after it reported lower iPhone sales than projected and warned that revenue in the current quarter might decline from the same period a year ago. Mr. Cook said he wanted to be ��ggressive��and ��pportunistic,��with the latest purchases bringing the total amount of stock bought back over the last 12 months to $40 billion. He added, ��t means that we are betting on Apple. It means that we are really confident on what we are doing and what we plan to do. We��e not just saying that. We��e showing that with our actions.��/p>

While Apple�� cash pile is often a hot topic for debate amongst analysts, it seems that the company is taking to heart the famous quotation from the Oracle of Omaha. And just to state the obvious, Tim Cook knows Apple better than everyone, so it bodes well for Apple�� future that the 8% price markdown after the earnings announcement signaled an opportunity to buy what he believed to be quality merchandise aggressively. With all of the discussion surrounding the share repurchase, let�� put the $14 billion into perspective just to illustrate the boldness of the move.

Best Telecom Stocks To Own Right Now: GlaxoSmithKline PLC(GSK)

GlaxoSmithKline plc, together with its subsidiaries, engages in the discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health-related consumer products worldwide. It offers pharmaceutical products in various therapeutic areas comprising respiratory, HIV, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, oncology and emesis, vaccines, and dermatologicals. The company provides prescription medicines to treat a range of conditions, including infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. It also markets a range of vaccines to prevent life-threatening or crippling illnesses, such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza, and bacterial meningitis. In addition, the company provides OTC medicines, including Panadol, a paracetamol-based treatment of headache and joi nt pain, fever, and cold symptoms; Gaviscon, a range of antacid products that relieve heartburn due to acid reflux; and NicoDerm, NiQuitin CQ, Nicabate, and Nicorette for the treatment of nicotine withdrawal as an aid to quit smoking. Further, it offers oral healthcare products comprising Sensodyne, a range of toothpastes and toothbrushes for the prevention of dental sensitivity; Aquafresh, a range of toothpastes, toothbrushes, and mouthwashes; and Polident, Poligrip, and Corega, which are denture adhesives and cleansers. Additionally, the company provides nutritional healthcare products consisting of Lucozade, an energy and sports drinks for energy and hydration; Horlicks, a malted, milk-based drink and food for nutrition application; and Ribena, an apple, orange, raspberry, and pomegranate flavored fruit drink, as well as markets skincare products. GlaxoSmithKline plc was incorporated in 1999 and is headquartered in Brentford, United Kingdom.

Advisors' Opinion:

• [By George Budwell]

  In a double whammy, GlaxoSmithKline (NYSE: GSK  ) reported at the same meeting that Tykerb failed to meet its primary endpoint of improved disease-free survival in a late-stage study in combination with Herceptin for HER2-positive early stage breast cancer in an adjuvant setting. Because PB272 is also being studied as a treatment for breast cancer in an adjuvant setting, investors appear to think Tykerb's failure bodes poorly for PB272.�

• [By Bryan Murphy]

  Anybody who knows at least something about Prosensa Holding NV (NASDAQ:RNA) will at least know the stock turned into a disaster a few weeks ago, plunging from a close of $24.00 on September 19th to a close of $7.14 on September 20th, thanks to the failure of its MS drug drisapersen, which was jointly developed with GlaxoSmithKline plc (NYSE:GSK). Such is the life of a company with only one drug anywhere close to being approved; drisapersen was in Phase 3 trials - RNA shares could have just as easily gained 70% rather than lost 70% had the drug worked.

5 Best Healthcare Technology Stocks To Watch Right Now: Suedzucker Mannheim Ochsenfurt AG (SZU)

Suedzucker Mannheim Ochsenfurt AG is a Germany-based company engaged in the processing of agricultural raw materials. The Company is organized, along with its subsidiaries, into four segments: the Sugar segment comprises sugar production and the agricultural division; the Special Products segment includes the activities of four divisions: BENEO, which produces and sells ingredients made from natural raw materials for food products and animal feed; the Freiberger Group is a producer of chilled and frozen pizzas, frozen pasta dishes and snacks; the PortionPack Europe group specializes in portion packs, and the starch division comprises starch companies in Hungary and Romania, bio-ethanol production in Austria and Hungary, as well as starch production facilities in Austria; the CropEnergies segment includes the bio-ethanol activities of the Company in Germany, Belgium and France, and the Fruit segment comprises the fruit juice preparations and fruit juice concentrates divisions. Advisors' Opinion:

• [By Jonathan Morgan]

  Volkswagen AG (VOW), Europe�� biggest automaker, climbed 3.7 percent as data showed European car sales increased for the first time in 19 months in April. Suedzucker AG (SZU) dropped to an eight-month low as J&E Davy Holdings Ltd. downgraded the shares.

5 Best Healthcare Technology Stocks To Watch Right Now: Atlas Air Worldwide Holdings(AAWW)

Atlas Air Worldwide Holdings, Inc. provides air cargo and outsourced aircraft operating solutions worldwide. The company operates through four segments: Aircraft, Crew, Maintenance, and Insurance (ACMI); Air Mobility Command (AMC) Charter; Commercial Charter; and Dry Leasing. The ACMI segment offers aircraft that is crewed, maintained, and insured by the company for lease. The AMC Charter segment provides full planeload charter flights to the U.S. military. The Commercial Charter segment provides planeload of capacity charter services to charter brokers, freight forwarders, direct shippers, and airlines. The Dry Leasing segment provides for the leasing of aircraft and/or engines to customers. The company operates a fleet of Boeing 747 freighters. Its customers include airlines, express delivery providers, freight forwarders, the U.S. military, and charter brokers. It operates in Asia, the Middle-East, Australia, Europe, South America, Africa, and North America. As of Decem ber 31, 2009, the company operated a fleet of 747-400 freighter aircraft. Atlas Air Worldwide Holdings was founded in 1992 and is based in Purchase, New York.

Advisors' Opinion:

• [By Ben Levisohn]

  Atlas Air Worldwide (AAWW) has plunged 21% to $38.63 following its announcement that it would earn less this year than it had previously expected.

  Oshkosh has dropped 12% to $46.25 after it reported a profit of 49 cents a share, missing forecasts for 590 cents, as sales of military vehicles plunged.

5 Best Healthcare Technology Stocks To Watch Right Now: Mostostroy No6 OAO (MSTF)

Mostostroy No6 OAO (Mostostroitel��yi trest No 6 OAO or Bridge Construction Trust N 6 OJSC) is a Russia-based company engaged in the construction industry. Its services portfolio includes the design, construction, reconstruction and renovation of bridges, railways, highways, tunnels and subways, nuclear and thermal power stations, residential and industrial facilities, among others. Mostostroitel��yi trest No 6 OAO provides its services mainly to companies engaged in the transportation, hydraulic engineering, industrial, civil and nuclear construction sectors and its customers include ROSATOM and Russian Railways, among others. The Company operates through 10 branches, as well as two representative offices, located in Moscow and Sochi. In addition, it has five wholly owned subsidiaries. As of March 4, 2011, the Company�� major shareholder was Malakhit OOO with a stake of 19.85%. Advisors' Opinion:

• [By Tom Taulli]

  But again, the most glaring red flag is the valuation of GOOG stock. Shares of Google stock are currently trading at a P/E ratio of 30, which is certainly rich. Consider that�Apple (AAPL) and �Microsoft (MSTF) sport multiples of only about 14. These companies also have decent dividend yields.